Drug Discount Monitor

April 2012 Headlines

340B Providers Urged to Test Their Compliance Systems

April 27, 2012 - Get ready for a possible audit by self-auditing now, peer advisers tell entities during webinar. Read more

OPA Issues 8 FAQs About 340B Hospital Recertification

April 24, 2012 - Answers questions that arose during February and March webinars. Read more

Influential Senator Seeks 7-Year Halt on 340B Pricing for Shortage-Prone Drugs

April 20, 2012 - Draft bill would also exempt manufacturers from Medicaid rebates on many sterile injectable drugs. Read more

OPA Holding 340B Recertification Webinar for Manufacturers & Wholesalers

April 20, 2012 - First batch of hospitals due to begin reaffirming eligibility today. Read more

OPA Sets Provisional Dates for Start of 340B Hospital Recertification

April 11, 2012 - Emails are slated to be sent on April 20, April 27, and May 4. Read more

How Would 340B Fare if Health Care Reform Is Struck Down?

April 6, 2012 - A Drug Discount Monitor news analysis. Read more

FTC Allows Express Scripts to Purchase Medco Health Solutions

April 4, 2012 - Dissenting commissioner calls the PBM merger a "game changer". Read more

Lilly Limits Zyprexa Sales as 340B Price Falls to a Penny

April 4, 2012 - Allocation system is the first since OPA issued policy clarification in November. Read more